Skip to content

The STavanger osteoARThritis Study

The STavanger osteoARThritis Study in Primary Health Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02876120
Acronym
START
Enrollment
330
Registered
2016-08-23
Start date
2016-09-30
Completion date
2017-11-30
Last updated
2018-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Knee Osteoarthritis

Brief summary

The START study will implement osteoarthritis (OA) treatment recommendations to increase the use of recommended treatment modalities and reduce non-desired events (e.g. unnecessary referrals to secondary care, unnecessary use of costly imaging modalities and use of treatment modalities supported by low quality of evidence). The purpose of the STavanger osteoARThritis (START) study is to improve the quality of OA care and increase the collaboration between health care professionals in primary health care and across health care levels.

Detailed description

Previous research has shown that the osteoarthritis care for persons with hip or knee osteoarthritis in Norway has a potential for improvement as the provided care may not necessarily reflect evidence-based guideline recommendations. The purpose of the STavanger osteoARThritis (START) study is to improve the quality of OA care and increase the collaboration between health care professionals in primary health care and across health care levels. Based on international treatment recommendations for OA care and previous research, a tailored implementation strategy targeting high quality, integrated care for people with OA in Stavanger Municipality will be developed, implemented and evaluated. The care will mainly be provided in the Stavanger primary health care services by physiotherapists (PT) (in private practice) and general practitioners (GP), but will also include collaboration with orthopaedic surgeons in specialist health care at Stavanger University Hospital. The main aim of the present study is to develop, implement and evaluate effects of a tailored implementation strategy for the START study in Stavanger Municipality. To evaluate the effects of the START implementation strategy, an interrupted time series design method will be applied. The study period will be divided into three phases: pre-implementation, implementation/transition and post-implementation. Data will be collected at 16 time points; 8 before and 8 after the implementation/ transition phase.

Interventions

OTHERImplementation

Multifaceted implementation strategy to implement evidence based international osteoarthritis treatment recommendations among GPs and PTs in private practice, template for PT discharge reports to GP, patient osteoarthritis education programs, and facilitate multidisciplinary collaboration between the PTs and GPs.

Sponsors

Stavanger Municipality
CollaboratorUNKNOWN
Helse Stavanger HF
CollaboratorOTHER_GOV
Diakonhjemmet Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* PT working in private practice in Stavanger Municipality * GP working in Stavanger Municipality * Person with complaints due to hip and/or knee osteoarthritis referred to physiotherapy in Stavanger Municipality * Person with complaints due to hip and/or knee osteoarthritis referred for assessment of joint replacement at Stavanger University Hospital

Exclusion criteria

* Persons referred to physiotherapy after a total joint replacement * Persons who do not understand the Norwegian language * Persons with cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Change in patient-reported quality of osteoarthritis care8 weeks pre-implementation vs. 8 weeks post-implementationUsing the OsteoArthritis Quality Indicator questionnaire

Secondary

MeasureTime frame
Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that leads to scheduled joint surgery8 weeks pre-implementation vs. 8 weeks post-implementation
Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that has taken an MRI and/or conventional radiographs for OA assessment8 weeks pre-implementation vs. 8 weeks post-implementation
Change in the number of PT discharge summaries to the referring GP8 weeks pre-implementation vs. 8 weeks post-implementation
Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that has explored non-surgical treatment modalities beforehand8 weeks pre-implementation vs. 8 weeks post-implementation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026